NEW YORK (MarketWatch) -- Human Genome Sciences, Inc. said Tuesday a Phase 2 clinical trial demonstrated that HGS-ETR1 "is well tolerated and can be administered safely in patients with advanced ...

About Albuferon Albuferon is a novel long-acting form of interferon alpha created by HGS using its proprietary albumin fusion technology.

Albuferon is a novel long-acting form of interferon alpha created by HGS using its proprietary albumin fusion technology. Albuferon results from the genetic fusion of human albumin and interferon ...

Benlysta has helped transform HGS's prospects, and analysts were quick to note that confirmatory Phase III data may well clear the way to the first new drug approval for lupus in more than 40 years.

Gen Alpha Is Different in So Many Ways, Including Their ‘Awkward Phase’—Here’s Why There's a misconception about many kids of Generation Alpha. Experts weigh in on why this generation may ...

The Phase IIb trial combined Albuferon with ribavirin against genotype 1 chronic hepatitis C. HGS says the data confirm that Albuferon is at least as effective as peginterferon alfa-2a while ...

Experts weigh in on why this generation may not be so different after all.Fact checked by Sarah ScottIf you’ve scrolled through recent end-of-school-year photos or passed a group of sephora tweens at ...

Intrepid Studios discusses plans and expectations in a roadmap update for Ashes of Creation Phase 3, showing The Anvils, Py’Rai, and Nicua.

AOZ73016QI, a 16-Phase, 2-rail controller specifically designed to the latest OpenVReg16 (OVR16) specifications from NVIDIA ...

Human anti-human antibody formation has not been detected. Conclusions: HGS-ETR2, a specific TRAIL R2 targeting agent, can be safely administered IV every 3 weeks at doses that reach plasma ...

HGS-ETR2 shows anti-tumor activity at doses ≥ 0.3 mg/kg in xenograft models, both as a single agent and in combination with chemotherapeutic agents. Methods: This phase 1, dose-escalation study ...

Alpha and Omega Semiconductor Limited, a designer, developer, and global supplier of a broad range of discrete power devices, wide bandgap power devices, power management ICs, and modules, today ...